These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1036815)

  • 1. Registry of prospective clinical trials second report.
    Verstraete M
    Thromb Haemost; 1976 Aug; 36(1):239-50. PubMed ID: 1036815
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
    Mehta JL; Kitchens CS
    Cardiovasc Clin; 1987; 18(1):163-79. PubMed ID: 3111692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology of fibrinolytics].
    Klöcking HP
    Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in mucopolysaccharides and ultrastructural alterations in experimental atheromatosis].
    López-Campos JL; Piñero J; Lasierra J; Navas P; Moreno J; Cobo R
    Rev Clin Esp; 1982 Apr; 165(1):15-21. PubMed ID: 6214825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic agents: efficacy in relation to evolution time and dose].
    García Frade LJ; Torrado MC; Loren M; Navarro JL
    Rev Clin Esp; 1989 Feb; 184(2):75-9. PubMed ID: 2502822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 10. The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
    Pedersen AK; FitzGerald GA
    Circulation; 1985 Dec; 72(6):1164-76. PubMed ID: 3905047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
    Stapel A; Geissler N; Mlasowsky B; Jung D
    Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of fibrinolytic agents.
    Sasahara AA; Wall RT; Harburg CB
    West J Med; 1981 Feb; 134(2):128-33. PubMed ID: 7222662
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems of thrombolytic therapy.
    Neilson RF; Davidson JF
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):51-64. PubMed ID: 8920633
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
    Zucker MB; Peterson J
    J Lab Clin Med; 1970 Jul; 76(1):66-75. PubMed ID: 5425364
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody reacting with platelets for monitoring thrombolysis.
    Wang GJ; Oster ZH; Som P; Zamora PO
    Int J Rad Appl Instrum B; 1991; 18(3):275-80. PubMed ID: 1906449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V; Pannell R
    Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.